Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹1150 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 28% |
Expense Ratio | 1.82 | 2.22 |
Manager | Sailesh Raj Bhan | Kamal Gada |
ISIN Code | INF204K01968 | INF789F01695 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | 3.05% | 2.41% |
6 Month | -0.1% | -2.35% |
1 Year | 14.95% | 20.85% |
3 Year | 22.97% | 23.63% |
5 Year | 22.83% | 22.48% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | -0.97% | -2.51% |
1 Year | -2.86% | -2.71% |
3 Year | 21.3% | 23.45% |
5 Year | 17.98% | 18.43% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 18.19% | 11.43% |
3 Year | 20.5% | 16.02% |
5 Year | 20.36% | 14.18% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.623% | 16.371% |
Sharp | 0.707% | 0.731% |
Beta | 0.908% | 0.958% |
Alpha | 0.486% | 0.84% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Sailesh Raj Bhan | Kamal Gada |
Total AUM | ₹96086 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.36 | 1.35 |
Large Cap | 38.72 | 28.87 |
Mid Cap | 32.78 | 26.26 |
Small Cap | 27.14 | 43.53 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.36 | 0.45 |
Healthcare | 98.64 | 98.22 |
Basic Materials | - | 1.33 |
Top Comparisons
Aditya Birla Sun Life Global Emerging Opportunities Fund - Regular Plan - Growth Option
3Y Returns12.67%
Aditya Birla Sun Life Global Excellence Equity Fund Of Fund- Retail Plan - Regular Plan - Growth Option
3Y Returns19.12%
Nippon India Focused Equity Fund -Growth Plan -Growth Option
3Y Returns18.86%
UTI Focused Fund- Regular Plan - Growth Option
3Y Returns19.12%
BANDHAN Government Securities Fund - IP - Regular Plan - Growth
3Y Returns8.61%
Invesco India GILT Fund - Growth
3Y Returns8.26%
SBI Short Horizon Debt Fund - Ultra Short Term Fund - Institutional Plan - Growth
3Y Returns6.85%
HSBC Ultra Short Duration Fund - Regular Growth
3Y Returns6.96%